{"data":[{"accessionNo":"0001422849-26-000080","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000875320","issuerName":"Vertex Pharmaceuticals Inc.","ticker":"VRTX","cusip":"92532F100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Capital World Investors","reportingCik":null,"personType":"IA","sharesOwned":25695015,"percentOfClass":10.1,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/vrtx"},{"accessionNo":"0001422848-26-000067","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000875320","issuerName":"Vertex Pharmaceuticals Inc.","ticker":"VRTX","cusip":"92532F100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Capital Research Global Investors","reportingCik":null,"personType":"IA","sharesOwned":21139169,"percentOfClass":8.3,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/vrtx"},{"accessionNo":"0002100119-26-001217","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000875320","issuerName":"Vertex Pharmaceuticals Inc","ticker":"VRTX","cusip":"92532F100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":19036076,"percentOfClass":7.49,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/vrtx"},{"accessionNo":"0000102909-26-002578","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0000875320","issuerName":"Vertex Pharmaceuticals Inc","ticker":"VRTX","cusip":"92532F100","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/vrtx"},{"accessionNo":"0001422848-26-000023","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000875320","issuerName":"Vertex Pharmaceuticals Inc.","ticker":"VRTX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Capital Research Global Investors","reportingCik":null,"personType":"IA","sharesOwned":17319044,"percentOfClass":6.8,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/vrtx"}],"updatedAt":"2026-10-29T04:34:04.652Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/vrtx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}